Latest News for: monte rosa

Edit

Notice of Effectiveness (Form EFFECT) (Monte Rosa Therapeutics Inc)

Public Technologies 01 Apr 2025
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION ... 20549 ... Form ... Monte Rosa Therapeutics, Inc ... Monte Rosa Therapeutics Inc.
Edit

AEVIS VICTORIA SA - The hotel branch of AEVIS VICTORIA recorded strong growth in 2024, driven by the quality of its assets and the strength of its integrated model.

Pharmiweb 01 Apr 2025
In Zermatt, the Group owns a unique real estate building complex including the Mont Cervin, Petit Cervin, Schweizerhof and Monte Rosa hotels, as well as several commercial premises, apartments and plots of land with high development potential.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Monte Rosa Therapeutics Inc)

Public Technologies 25 Mar 2025
) FORM 4. Check this box if no longer subject to Section 16 ... See Instruction 1(b) ... See Instruction 10 ... Monte Rosa Therapeutics, Inc ... MONTE ROSA THERAPEUTICS, INC., 321 HARRISON AVENUE, SUITE 900 3 ... MONTE ROSA THERAPEUTICS, INC ... Monte Rosa Therapeutics Inc.
Edit

Monte Rosa Corporate Presentation – March 2025 (Monte Rosa Therapeutics Inc)

Public Technologies 20 Mar 2025
Monte Rosa Therapeutics - Company Overview ... Monte Rosa's rationally designed MGDs have potential applications in oncology, ... Monte Rosa Pipeline and Upcoming Milestones ... * Monte Rosa has an exclusive global license agreement with Novartis for this asset.
Edit

Initial Registration Statement for Employee Benefit Plan (Form S-8) (Monte Rosa Therapeutics Inc)

Public Technologies 20 Mar 2025
). As filed with the Securities and Exchange Commission on March 20, 2025 ... MONTE ROSA THERAPEUTICS, INC ... Monte Rosa Therapeutics, Inc ... Monte Rosa Therapeutics, Inc ... Monte Rosa Therapeutics, Inc ... ☐ ... ☐ ... MONTE ROSA THERAPEUTICS, INC ... Monte Rosa Therapeutics Inc.
Edit

Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs (Form 8-K) (Monte Rosa Therapeutics Inc)

Public Technologies 20 Mar 2025
Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs ... BOSTON, Mass., March 20, 2025 - Monte Rosa Therapeutics, Inc ... About Monte Rosa.
Edit

Annual Report for Fiscal Year Ending 12-31, 2024 (Form 10-K) (Monte Rosa Therapeutics Inc)

Public Technologies 20 Mar 2025
Monte Rosa Therapeutics AG, a Swiss operating company, was incorporated under the laws of Switzerland in April 2018. Monte Rosa Therapeutics, Inc ... includes wholly owned subsidiaries Monte Rosa Therapeutics AG and Monte Rosa Securities Corporation.
Edit

Registration Statement - Specified Transactions (Form S-3) (Monte Rosa Therapeutics Inc)

Public Technologies 20 Mar 2025
As used in this prospectus, unless the context otherwise requires, references to the “Monte Rosa,” “company,” “we,” “us” and “our” refer to Monte Rosa Therapeutics, Inc.
  • 1
×